The biguanide metformin has been studied in the context of exercise capacity, quality of life and mood states, and metabolic adaptations, such as insulin production and clearance, oxidative stress and cardiometabolic health in older adults with prediabetes and Type II diabetes [16–18]. This evidence concerns the gene INS and type 2 diabetes mellitus.